Related Experiment Videos
[Clinical efficacy of clarithromycin in the field of pediatrics]
Insights
Clarithromycin (TE-031) demonstrated excellent clinical efficacy in pediatric patients across various infections. This new macrolide antibiotic showed no significant side effects in infants and children.
Area of Science:
- Pediatric infectious diseases
- Pharmacology of macrolide antibiotics
Background:
- Evaluation of clarithromycin (TE-031), a novel macrolide antibiotic, for pediatric use.
- Assessing the safety and efficacy of clarithromycin in treating common childhood infections.
Observation:
- A total of 18 pediatric patients (2 months to 11 years) were treated with clarithromycin.
- Infections included acute bronchitis, tonsillitis, Mycoplasma pneumonia, pertussis, scarlatina, and enteritis.
- Dosage ranged from 19.7-43.5 mg/kg daily for 4-19 days.
Findings:
- Excellent or good clinical efficacy was observed in all 18 cases (11 excellent, 7 good).
- No adverse clinical side effects were reported.
- No abnormal laboratory test values were attributed to clarithromycin.
Implications:
- Clarithromycin is a safe and effective treatment option for various pediatric infections.
- Supports the use of clarithromycin in pediatric infectious disease management.
- Highlights the potential of new macrolides in combating childhood illnesses.
Abstract:
A new macrolide antibiotic, clarithromycin (TE-031, A-56268), was studied for its clinical efficacy in the field of pediatrics. Patients treated were infants and children ranging from 2 months to 11 years old suffering from acute bronchitis in 5 cases, acute tonsillitis in 2 cases, Mycoplasma pneumonia in 2 cases, pertussis in 6 cases, scarlatina in 1 case and acute enteritis in 2 cases, a total of 18 cases. TE-031 was administered 19.7-43.5 mg/kg in daily doses and lengths of treatment ranged from 4 to 19 days. As regards to its clinical efficacy, good or excellent results were obtained in all cases: excellent in 11 cases and good in 7 cases. No clinical side effects nor abnormal laboratory test values obviously attributable to TE-031 were observed.